Article Series
Comparison of Percent-Free PSA, PSA Density, and Age-Specific PSA Cutoffs for Prostate Cancer Detection and Staging
W.J. Catalona; P.C. Southwick; K.M. Slawin; A.W. Partin; M.K. Brawer; R.C. Flanigan, et al. Urology, August 2000
This study concludes that the percent-free PSA test was either equal to or better than two other methods of detecting prostate cancer. Researchers examined three methods: age-specific PSA reference ranges, PSA density (PSAD), and percent-free PSA. Researchers found that the free PSA assay was significantly better than age-specific PSA reference ranges. Percent-free PSA and PSA density provided equally accurate results. This paper states the free PSA assay may be used in place of PSAD to determine whether a biopsy was necessary and to help make treatment decisions.
The Prostate Cancer Education Council's Article Series consists of articles written by a select panel of distinguished urologists from across the nation. Each article addresses a topic related to advancements in prostate cancer treatment, research, and prevention. Informative sidebars accompany each segment, along with highlighted technical vocabulary hyperlinked to a prostate cancer glossary, creating an easily digestible format for consumers.
The current article series includes:
Value of PSA and Free PSA Tests Validated in New Prostate Cancer Guidelines
Features William J. Catalona, M.D., professor at Washington University in St. Louis
PSA Test a Cause for Concern? Not So Fast
Features William J. Catalona, M.D., professor at Washington University in St. Louis
PSA: What's the Prognosis?
Features William J. Catalona, M.D., professor at Washington University in St. Louis
Evaluating PSA Levels in Men on Oral Medication to Treat Prostate Disease
Features William J. Catalona, M.D., professor at Washington University in St. Louis
5 in 5: Take Five Minutes for Five Questions about Prostate Cancer
Mark A. Moyad, MD, MPH ; Phil F Jenkins, Director of Complementary/Preventive Medicine
Selenium and Vitamin E Supplements for Prostate Cancer: Evidence or Embellishment?
Mark A. Moyad, MPH
The Role of Urodynamics in Assessing Symptomatic Benign Prostatic Hyperplasia
Ian K. Walsh, MD, FRCS; Anthony R. Stone, MD, FRCS
Immediate versus Delayed Therapy for Prostate Cancer: Earlier is Better
E. David Crawford, M.D.
Use of the LigaSure™ Vessel Sealing System in Urologic Cancer Surgery
E. David Crawford, MD; Jenifer S. Kennedy, PhD; Vonne Sieve
